loading
Precedente Chiudi:
$3.62
Aprire:
$3.52
Volume 24 ore:
97,042
Relative Volume:
0.13
Capitalizzazione di mercato:
$70.26M
Reddito:
$264.74M
Utile/perdita netta:
$-49.71M
Rapporto P/E:
-0.8447
EPS:
-4.0959
Flusso di cassa netto:
$-43.55M
1 W Prestazione:
+5.93%
1M Prestazione:
+7.23%
6M Prestazione:
+95.79%
1 anno Prestazione:
-64.26%
Intervallo 1D:
Value
$3.31
$3.59
Intervallo di 1 settimana:
Value
$3.11
$3.83
Portata 52W:
Value
$1.305
$12.26

Camp 4 Therapeutics Corp Stock (CAMP) Company Profile

Name
Nome
Camp 4 Therapeutics Corp
Name
Telefono
617-651-8867
Name
Indirizzo
ONE KENDALL SQUARE, CAMBRIDGE, CA
Name
Dipendente
55
Name
Cinguettio
@calamp
Name
Prossima data di guadagno
2024-07-25
Name
Ultimi documenti SEC
Name
CAMP's Discussions on Twitter

Confronta CAMP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CAMP
Camp 4 Therapeutics Corp
3.485 74.80M 264.74M -49.71M -43.55M -4.0959
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
415.18 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
478.50 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
574.32 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
804.78 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
319.77 35.92B 4.56B -176.77M 225.30M -1.7177

Camp 4 Therapeutics Corp Stock (CAMP) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-02 Iniziato Cantor Fitzgerald Overweight
2025-09-16 Downgrade JP Morgan Overweight → Neutral
2025-05-27 Iniziato Wedbush Outperform
2024-11-05 Iniziato JP Morgan Overweight
2024-11-05 Iniziato Piper Sandler Overweight
2024-11-05 Iniziato William Blair Outperform
2022-08-16 Aggiornamento Craig Hallum Hold → Buy
2021-12-22 Downgrade Craig Hallum Buy → Hold
2021-09-24 Reiterato Craig Hallum Buy
2021-06-25 Reiterato Craig Hallum Buy
2020-12-18 Downgrade JP Morgan Neutral → Underweight
2020-04-17 Aggiornamento Jefferies Hold → Buy
2020-03-05 Reiterato Craig Hallum Buy
2019-12-20 Reiterato Craig Hallum Buy
2019-12-20 Downgrade First Analysis Sec Outperform → Neutral
2019-06-28 Aggiornamento Northland Capital Market Perform → Outperform
2019-05-29 Downgrade Goldman Neutral → Sell
2019-05-01 Reiterato Craig Hallum Buy
2019-03-25 Downgrade JP Morgan Overweight → Neutral
2019-01-25 Aggiornamento JP Morgan Neutral → Overweight
2018-12-21 Aggiornamento Craig Hallum Hold → Buy
2018-12-14 Reiterato B. Riley FBR Buy
2018-12-11 Downgrade First Analysis Sec Strong Buy → Outperform
2018-12-11 Downgrade Northland Capital Outperform → Market Perform
2018-11-27 Iniziato Goldman Neutral
2018-10-15 Iniziato Jefferies Hold
2018-09-28 Reiterato Craig Hallum Hold
2018-04-27 Reiterato Craig Hallum Hold
2018-03-08 Downgrade Craig Hallum Buy → Hold
2018-02-16 Aggiornamento First Analysis Sec Equal-Weight → Overweight
Mostra tutto

Camp 4 Therapeutics Corp Borsa (CAMP) Ultime notizie

pulisher
Oct 13, 2025

How Camp4 Therapeutics Corporation stock reacts to global recession fears2025 Risk Factors & Safe Swing Trade Setup Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Risk adjusted return profile for Camp4 Therapeutics Corporation analyzedJuly 2025 Trade Ideas & Entry Point Confirmation Signals - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is Camp4 Therapeutics Corporation a good long term investmentCup and Handle Formations & Low Entry Investment Portfolio - earlytimes.in

Oct 13, 2025
pulisher
Oct 11, 2025

Combining price and volume data for Camp4 Therapeutics CorporationShort Setup & Technical Analysis for Trade Confirmation - newser.com

Oct 11, 2025
pulisher
Oct 10, 2025

Can Camp4 Therapeutics Corporation stock reach $100 price targetPortfolio Performance Summary & Weekly Market Pulse Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will Camp4 Therapeutics Corporation continue its uptrendPortfolio Return Report & AI Powered Market Entry Ideas - newser.com

Oct 10, 2025
pulisher
Oct 08, 2025

CAMP4 Therapeutics stock soars after $100 million private placement By Investing.com - Investing.com Nigeria

Oct 08, 2025
pulisher
Oct 03, 2025

CAMP4 Aims For The Summit: Unlocking The Therapeutic Power Of RegRNA, Once Deemed Undruggable - RTTNews

Oct 03, 2025
pulisher
Oct 02, 2025

Camp4 Therapeutics Corporation Stock Analysis and ForecastSector Performance Review & Unlock Long-Term Capital Growth Ideas - earlytimes.in

Oct 02, 2025
pulisher
Oct 02, 2025

Cantor Fitzgerald initiates CAMP4 Therapeutics stock with Overweight rating - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

CAMP4 Therapeutics begins toxicology studies for SYNGAP1 therapy By Investing.com - Investing.com Nigeria

Oct 02, 2025
pulisher
Oct 01, 2025

Camp4 Therapeutics initiates GLP toxicology studies for CMP-SYNGAP-01 - MarketScreener

Oct 01, 2025
pulisher
Oct 01, 2025

CAMP4 Initiates GLP Toxicology Studies for CMP-SYNGAP-01 - TipRanks

Oct 01, 2025
pulisher
Oct 01, 2025

CAMP4 Therapeutics begins toxicology studies for SYNGAP1 therapy - Investing.com India

Oct 01, 2025
pulisher
Oct 01, 2025

CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01 - GlobeNewswire

Oct 01, 2025
pulisher
Oct 01, 2025

Potential Breakthrough for Rare Brain Disorder: CAMP4's SYNGAP1 Drug Enters Final Pre-Clinical Stage - Stock Titan

Oct 01, 2025
pulisher
Sep 28, 2025

What analysts say about Camp4 Therapeutics Corporation stockReal Estate Investment Trusts & These 3 Stocks Could Change Your Portfolio - Early Times

Sep 28, 2025
pulisher
Sep 25, 2025

CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Sep 25, 2025
pulisher
Sep 24, 2025

Price action breakdown for Camp4 Therapeutics CorporationWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com

Sep 24, 2025
pulisher
Sep 23, 2025

What’s next for Camp4 Therapeutics Corporation stock priceWeekly Trend Summary & Low Risk High Win Rate Stock Picks - newser.com

Sep 23, 2025
pulisher
Sep 22, 2025

Is Camp4 Therapeutics Corporation reversing from oversold territoryJuly 2025 Big Picture & High Accuracy Trade Signal Alerts - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Applying chart zones and confluence areas to Camp4 Therapeutics CorporationMarket Growth Report & Free Long-Term Investment Growth Plans - newser.com

Sep 22, 2025
pulisher
Sep 20, 2025

Backtesting results for Camp4 Therapeutics Corporation trading strategiesVolume Spike & Real-Time Volume Analysis Alerts - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

How institutional ownership impacts Camp4 Therapeutics Corporation stockChart Signals & Safe Entry Momentum Tips - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Building trade automation scripts for Camp4 Therapeutics CorporationOptions Play & Consistent Profit Focused Trading Strategies - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Aug Spikes: Whats the beta of LILAK stockJuly 2025 Movers & Verified Momentum Stock Ideas - khodrobank.com

Sep 20, 2025
pulisher
Sep 19, 2025

Trend analysis for Camp4 Therapeutics Corporation this weekCPI Data & High Return Stock Watch Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Analyzing Camp4 Therapeutics Corporation with multi timeframe chartsWeekly Trade Recap & Breakout Confirmation Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Aug Movers: Will Camp4 Therapeutics Corporation outperform the market in YEAR2025 Trading Recap & Real-Time Stock Entry Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Patterns Watch: What are Camp4 Therapeutics Corporation’s recent SEC filings showingOptions Play & High Accuracy Swing Entry Alerts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Using AI based signals to follow Camp4 Therapeutics CorporationM&A Rumor & AI Optimized Trade Strategies - newser.com

Sep 19, 2025
pulisher
Sep 18, 2025

Earnings Recap: Can ProShares Trust ProShares UltraShort SmallCap600 beat the S&P 500Quarterly Market Summary & Weekly High Return Stock Forecasts - خودرو بانک

Sep 18, 2025
pulisher
Sep 17, 2025

Support Test: Is Camp4 Therapeutics Corporation likely to announce a buybackJuly 2025 Gainers & Weekly Consistent Profit Watchlists - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

Can volume confirm reversal in Camp4 Therapeutics CorporationJuly 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com

Sep 16, 2025

Camp 4 Therapeutics Corp Azioni (CAMP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Camp 4 Therapeutics Corp Azioni (CAMP) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Polaris Management Co. VII, L.
10% Owner
Sep 11 '25
Buy
1.53
1,307,189
1,999,999
2,825,500
Nashat Amir
Director
Sep 11 '25
Buy
1.53
1,307,189
1,999,999
2,825,500
Maricich Yuri
Chief Medical Officer
Sep 11 '25
Buy
1.65
6,060
9,999
6,060
Gold Kelly
Chief Financial Officer
Sep 11 '25
Buy
1.65
6,060
9,999
67,877
Mandel-Brehm Josh
Chief Executive Officer
Sep 11 '25
Buy
1.65
6,060
9,999
278,417
Young Richard A
Director
Sep 11 '25
Buy
1.65
15,151
24,999
170,010
Northpond Ventures II GP, LLC
10% Owner
Oct 15 '24
Buy
11.00
763,636
8,399,996
763,636
AH Equity Partners Bio I, L.L.
10% Owner
Oct 15 '24
Buy
11.00
727,272
7,999,992
1,579,885
Enavate Sciences GP, LLC
10% Owner
Oct 15 '24
Buy
11.00
1,363,636
14,999,996
3,785,802
Polaris Management Co. VII, L.
10% Owner
Oct 15 '24
Buy
11.00
909,090
9,999,990
909,090
$21.96
price down icon 4.32%
$85.09
price up icon 0.42%
$32.80
price up icon 0.22%
$103.03
price up icon 0.59%
$162.46
price down icon 0.89%
biotechnology ONC
$319.74
price down icon 2.03%
Capitalizzazione:     |  Volume (24 ore):